Arvaya Healthcare Approves Acquisition of SIGPL, Outlines Rights Issue and Board Appointments

Arvaya Healthcare Approves Acquisition of SIGPL, Outlines Rights Issue and Board Appointments​

Arvaya Healthcare Limited announced several strategic decisions following its Board of Directors meeting on July 11, 2026. Key approvals include the acquisition of 100% equity in M/s Sushodha Institute of Gastroenterology Private Limited (SIGPL), the approval of a preferential issue, and the greenlighting of a future Rights Issue. The company also formalized changes to its registered office and appointed new directors for affiliated entities.

Acquisition of SIGPL​

The Board approved the acquisition of 100% equity shares of Sushodha Institute of Gastroenterology Private Limited (SIGPL) for a total purchase consideration of Rs. 15,48,74,160/-. This acquisition involves 184,374 equity shares in SIGPL at a price of Rs. 840/- per share.

The purchase consideration will be discharged through the issue and allotment of up to 38,71,854 fully paid-up equity shares of Arvaya Healthcare Limited (Face value: Rs. 10; Issue price: Rs. 40, including a premium of Rs. 30).

The transaction is noted as being at arm's length and was conducted based on a valuation report provided by Mr. Shreyas Bharat Ohara, Registered Valuer. The company aims to achieve business synergies, operational efficiencies, expand its hospital and diagnostic footprint, and enhance revenue streams through integrated healthcare offerings.

Regarding SIGPL’s background, the company operates as an exclusive super-specialty gastroenterology hospital in Shivamogga, providing specialized services focused on diagnosis, medical and surgical treatment, endoscopy, gastrointestinal care, and allied healthcare services. The financial history of SIGPL is summarized below:


The Board noted that the acquisition is a related party transaction, involving shareholders of both SIGPL and Arvaya Healthcare Ltd. Mr. Bidari Kotresh Anilkumar and Mr. Dhanaji Dattatray Jadhav are listed as related parties in relation to this deal, confirming the transaction was conducted at arm's length.

Financial and Governance Initiatives​

The Board also approved a preferential issue through a private placement for shareholders of SIGPL. This issuance involves 38,71,854 equity shares of Arvaya Healthcare Limited (Face value: Rs. 10; Issue Price: Rs. 40, including a premium of Rs. 30) for a total amount of Rs. 15,48,74,160/- when discharged through the acquisition.

To manage potential future expansion, the Board approved the fundraising via a Rights Issue of Specified Securities to eligible equity shareholders, setting a maximum issue amount not exceeding Rs. 210 Crores. A dedicated Rights Issue Committee was also constituted for this purpose and comprises Mr. Kaushal Uttam Shah (Chairman), Mr. Salil Shetty, and Mr. Rahul Ravindra Mayur.

In corporate appointments, the Board approved two non-executive director positions at SMCV Management Services Private Limited: Mr. Kaushal Shah, Managing Director of Arvaya Healthcare Ltd., and Mr. Ranganath Abhiram, Chief Financial Officer of the company.

Operational Updates and Postal Ballot Timeline​

The company is undergoing a change in its registered office location, shifting from Nirvana Co Working spaces in Guwahati, Assam, to Unit No 408 Third floor Royal Miraj Arcade in Sangli, Maharashtra. This move remains subject to necessary approvals under the Companies Act, 2013.

The Board of Directors also considered and approved conducting a postal ballot process. Mr. Chinmay Mohan Lele, Practicing Company Secretary, was appointed as the Scrutinizer for this process. The timeline established for the E-voting and Postal Ballot is as follows:

Stock Price Movement​

Arvaya Healthcare Ltd shares settled at ₹85.62 on Friday, registering a strong gain of 4.99% in the post-market session. The stock remained completely flat throughout the day, as its intraday high and low were locked at ₹85.62.